2024
An Update on the Survival of the First 50 Face Transplants Worldwide
Homsy P, Huelsboemer L, Barret J, Blondeel P, Borsuk D, Bula D, Gelb B, Infante-Cossio P, Lantieri L, Mardini S, Morelon E, Nasir S, Papay F, Petruzzo P, Rodriguez E, Özkan Ö, Özmen S, Pomahac B, Lassus P. An Update on the Survival of the First 50 Face Transplants Worldwide. JAMA Surgery 2024, 159 PMID: 39292472, PMCID: PMC11411447, DOI: 10.1001/jamasurg.2024.3748.Peer-Reviewed Original ResearchOverall survivalRejection episodesFace transplantationTransplanted graftsMedian follow-up timeAcute rejection episodesFollow-up timePredictors of survivalMulticenter cohort studyExtensive facial defectsEpisodes per yearLong-term survivalTransplant variablesFacial defectsNonpublished dataTransplant lossMedian numberFollow-upCohort studyReconstructive optionsPrimary outcomeSecondary outcomesTransplant survivalTransplantationTransplant centers
2011
Evolution of indications for facial transplantation
Pomahac B, Diaz-Siso J, Bueno E. Evolution of indications for facial transplantation. Journal Of Plastic Reconstructive & Aesthetic Surgery 2011, 64: 1410-1416. PMID: 21843979, DOI: 10.1016/j.bjps.2011.06.024.Peer-Reviewed Original ResearchConceptsLong-term outcomesFace transplantationUnknown long-term outcomesAbsolute exclusion criteriaInstitutional review board approvalExpansion of indicationsReview board approvalPartial face transplantationFacial transplantationFacial defectsEvolution of indicationsSevere facial defectsFacial functionLifelong immunosuppressionCurrent indicationsExclusion criteriaBoard approvalTransplantationSafe reductionSensory functionPatientsPotential patientsTransplantation studiesImmunosuppressionIndications